Auvi-q Injection, Solution
Product Images NDC 85766-277

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 85766-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Auvi Q 01)

Chemical structure of epinephrine depicted as a molecular diagram showing its aromatic ring, hydroxyl groups, and side chains in a 2D format.*

FDA Label Image

Figure A (Auvi Q 02)

An instructional diagram of the Auvi-Q epinephrine injection device and its outer case showing key parts labeled. The device features a speaker, viewing window, LED lights, a red safety guard at the needle end, and a black base. The outer case is shown with a green upward arrow for orientation.*

FDA Label Image

Figure B (Auvi Q 03)

An instructional diagram showing two hands holding an Auvi-Q epinephrine injection device. Arrows indicate to slide the outer case up to expose the device, instructing proper handling before use.*

FDA Label Image

Figure C (Auvi Q 04)

An instructional illustration showing a hand holding an Auvi-Q epinephrine autoinjector. The image includes a close-up of pulling the red safety release tab downward, indicated by black arrows, demonstrating how to prepare the device for use.*

FDA Label Image

Figure D (Auvi Q 05)

Illustration showing a hand holding an Auvi-Q injection device near the leg with an arrow indicating injection direction, alongside a stopwatch displaying a 2-second interval. This diagram likely depicts the correct intramuscular injection technique and recommended injection time for Auvi-Q epinephrine injection.*

FDA Label Image

Figure E (Auvi Q 06)

An instructional illustration showing a person holding an Auvi-Q epinephrine injection device against their thigh. The image highlights the importance of holding the device in place for about 2 seconds, as emphasized by a stopwatch graphic on the right indicating a 2-second duration.*

FDA Label Image

Figure A1 (Auvi Q 07)

An instructional diagram of the Auvi-Q Trainer, an epinephrine injection training device. The image labels components including the outer case, device housing, safety guard, base, speaker, and LED indicators. It includes brief usage instructions for the trainer device shown on its front.*

FDA Label Image

Figure A2 (Auvi Q 08)

Packaging label for Auvi-Q Trainer, an epinephrine injection training device. The label shows the word 'TRAINER' prominently on the top, with Auvi-Q Trainer branding underneath. This label is for a non-medicated training product by Sportpharm LLC, designed to simulate the epinephrine injection experience without delivering an actual dose.*

FDA Label Image

Figure A3 (Auvi Q 09)

Auvi-Q 0.3 mg auto-injector packaging and device label with epinephrine injection, USP, for intramuscular use. The box features red and navy colors with instructions to pull the device from the case. The injector device label has step-by-step directions for use in allergic emergencies, including pulling the red safety guard, placing the device against the outer thigh, and pushing firmly for 2 seconds. Labeler is Sportpharm LLC.*

FDA Label Image

Figure A4 (Auvi Q 10)

Auvi-Q epinephrine injection, USP 0.15 mg auto-injector packaging label. The label is primarily blue with yellow and red accents, displaying usage instructions for allergic emergencies including pulling the red safety guard and pushing the black end firmly against the outer thigh. The labeler is Sportpharm LLC. The package warns to seek medical attention after use and indicates it is for single-use injection for patients weighing 33 to 66 lbs.*

FDA Label Image

Figure A5 (Auvi Q 11)

Packaging label for Auvi-Q epinephrine injection USP 0.1 mg auto-injector by Sportpharm LLC. The front panel shows the product name, strength, dosage form, and indication for allergic emergencies in patients weighing 16.5 to 33 lb. The back panel provides detailed instructions to pull the red safety guard, place the black end against the thigh, and push firmly and hold for 2 seconds to activate the injection, with caution to seek medical attention afterward.*

FDA Label Image

Figure B (Auvi Q 12)

Illustration showing a hand holding an Auvi-Q epinephrine injection device, with arrows indicating how to remove the device from its outer case by pulling upward and downward. The image demonstrates the correct method to access the intramuscular injection, highlighting the action of pulling apart the device components.*

FDA Label Image

Figure C (Auvi Q 13)

An instructional illustration showing a hand holding the Auvi-Q epinephrine injection device. The diagram indicates pulling the red safety guard at the bottom of the device, with arrows pointing downward to guide the user to remove it before use.*

FDA Label Image

Figure D (Auvi Q 14)

An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device against the outer thigh, with an inset image of a stopwatch highlighting a 2-second duration. The illustration demonstrates the proper method and timing for administering the intramuscular injection.*

FDA Label Image

Figure E (Auvi Q 15)

An instructional illustration showing the administration of Auvi-Q (epinephrine injection, solution) via intramuscular route. One hand holds the device against a thigh, with red concentric circles indicating the injection site. A stopwatch graphic indicates holding the device for 2 seconds during administration.*

FDA Label Image

Figure F (Auvi Q 16)

An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image includes text instructions: 'DO NOT HOLD BLACK BASE while inserting Red Safety Guard,' with arrows indicating the motion of removing or inserting the safety guard at the device's base.*

FDA Label Image

Figure G (Auvi Q 17)

An instructional illustration showing a person holding an Auvi-Q epinephrine injection device. The image highlights actions of pushing or sliding components in opposite directions with arrows, demonstrating how to open or prepare the auto-injector for use.*

FDA Label Image

0.15 (Label 0 15mg)

Label for Auvi-Q, epinephrine injection, USP 0.15 mg auto-injector, relabeled for Sportpharm LLC. The label shows an NDC 85766-276-02, quantity 2, and indicates it is manufactured for kaleo, Inc. It includes batch, lot, and expiration placeholder numbers, and directions for prescription use and storage instructions.*

FDA Label Image

0.1 (Label 0 1mg)

Label for Auvi-Q epinephrine injection 0.1 mg auto-injector, relabeled for SportPharm LLC. The label shows NDC 85768-275-02, quantity of 2 auto-injectors, with batch and lot numbers, expiration date placeholders, and a QR code. The original manufacturer is kaleo, Inc., with a source NDC 60842-021-02. Storage instructions and drug status are included.*

FDA Label Image

0.3 (Label 0 3mg)

Packaging label for Auvi-Q epinephrine injection USP 0.3 mg auto-injector, labeled for Sportpharm LLC. The label indicates a quantity of 2 auto-injectors, manufactured for kaleo, Inc. It includes the NDC code 85766-277-02, and shows placeholders for serial number, lot number, and expiration date. Warnings to keep out of reach of children and storage instructions are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.